Health Care & Life Sciences » Biotechnology | Cerenis Therapeutics Holding

Cerenis Therapeutics Holding S.A. | Balance Sheet

Fiscal year is January-December. All values EUR Thousands.
2013
2014
2015
2016
2017
2018
Cash & Short Term Investments
11,141.00
7,843.00
42,951.00
24,675.00
16,272.00
11,457
Total Accounts Receivable
2,056.00
1,609.00
2,274.00
3,767.00
1,458.00
1,299
Other Current Assets
562.00
1,312.00
436.00
280.00
138.00
28
Total Current Assets
13,759.00
10,764.00
45,661.00
28,722.00
17,868.00
12,784
Net Property, Plant & Equipment
150.00
61.00
169.00
122.00
82.00
23
Total Investments and Advances
15.00
12.00
12.00
12.00
12.00
15
Intangible Assets
1.00
-
8.00
5.00
214.00
213
Other Assets
-
-
257.00
204.00
121.00
100
Total Assets
13,925.00
10,837.00
46,107.00
29,065.00
18,297.00
13,135
ST Debt & Current Portion LT Debt
300.00
-
-
300.00
400.00
Accounts Payable
2,563.00
4,269.00
5,071.00
5,415.00
2,522.00
Income Tax Payable
24.00
23.00
12.00
18.00
25.00
Other Current Liabilities
192.00
409.00
707.00
961.00
290.00
Total Current Liabilities
3,079.00
4,701.00
5,790.00
6,694.00
3,237.00
Long-Term Debt
4,048.00
4,992.00
6,094.00
6,755.00
5,823.00
Provision for Risks & Charges
636.00
1,132.00
1,025.00
1,006.00
349.00
Total Liabilities
7,763.00
10,825.00
12,909.00
14,455.00
9,409.00
Common Equity (Total)
6,162.00
12.00
33,198.00
14,610.00
8,888.00
Total Shareholders' Equity
6,162.00
12.00
33,198.00
14,610.00
8,888.00
Total Equity
6,162.00
12.00
33,198.00
14,610.00
8,888.00
Liabilities & Shareholders' Equity
13,925.00
10,837.00
46,107.00
29,065.00
18,297.00

About Cerenis Therapeutics Holding

View Profile
Address
33-43, av. Georges Pompidou- Bât. D2
Balma Midi-Pyrenees 31130
France
Employees -
Website http://www.cerenis.com
Updated 07/08/2019
Cerenis Therapeutics Holding SA is a biopharmaceutical company, which engages in development of high density lipoprotein therapies for the treatment of cardiovascular and metabolic diseases. Its therapies consist of CER 001 and 209. The company was founded by Jean-Louis Dasseux on March 24, 2005 and is headquartered in Labege, France.